Incannex Healthcare Investor Relations Material

Incannex Healthcare Inc. is a clinical-stage pharmaceutical company focused on developing medicinal cannabis and psychedelic pharmaceutical products. The company is engaged in the research, development, and commercialization of therapies aimed at addressing a range of medical conditions. These include obstructive sleep apnea (OSA), traumatic brain injury (TBI), lung inflammation, rheumatoid arthritis, inflammatory bowel disease, anxiety, addiction, and chronic pain. Incannex Healthcare's product portfolio consists of both cannabinoid-based formulations and novel psychedelic therapies, which are in various stages of clinical development. The company is headquartered in Sydney, Australia, and its shares are listed on the NASDAQ.